Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1643

  • Showing results for milan plus. Your search for Milan Pleus retrieved no results.
1.

Reduced brain UCP2 expression mediated by microRNA-503 contributes to increased stroke susceptibility in the high-salt fed stroke-prone spontaneously hypertensive rat.

Rubattu S, Stanzione R, Bianchi F, Cotugno M, Forte M, Ragione FD, Fioriniello S, D'Esposito M, Marchitti S, Madonna M, Baima S, Morelli G, Sciarretta S, Sironi L, Gelosa P, Volpe M.

Cell Death Dis. 2017 Jun 22;8(6):e2891. doi: 10.1038/cddis.2017.278.

PMID:
28640254
2.

A novel system for the treatment of aortic annular dilation: an ex vivo investigation.

Shah P, Romagnoni C, Jaworek M, Lucherini F, Contino M, Menkis A, Gelpi G, Fiore GB, Antona C, Vismara R.

Eur J Cardiothorac Surg. 2017 Jun 15. doi: 10.1093/ejcts/ezx203. [Epub ahead of print]

PMID:
28633398
3.

Antitumor activity and safety profile of weekly carboplatin plus paclitaxel in metastatic breast cancer: a ten-year, monocentric, retrospective study.

Vernieri C, Milano M, Mennitto A, Maggi C, Ferrari B, Rinaldi L, Mennitto R, Stefanetti C, Re B, Mariani G, Bianchi G, Capri G, de Braud F.

Breast Cancer Res Treat. 2017 Jun 14. doi: 10.1007/s10549-017-4336-z. [Epub ahead of print]

PMID:
28616768
4.

Lambert-Eaton myasthenic syndrome (LEMS): a rare autoimmune presynaptic disorder often associated with cancer.

Schoser B, Eymard B, Datt J, Mantegazza R.

J Neurol. 2017 Jun 12. doi: 10.1007/s00415-017-8541-9. [Epub ahead of print] Review.

PMID:
28608304
5.

TRIBE-2: a phase III, randomized, open-label, strategy trial in unresectable metastatic colorectal cancer patients by the GONO group.

Cremolini C, Marmorino F, Loupakis F, Masi G, Antoniotti C, Salvatore L, Schirripa M, Boni L, Zagonel V, Lonardi S, Aprile G, Tamburini E, Ricci V, Ronzoni M, Pietrantonio F, Valsuani C, Tomasello G, Passardi A, Allegrini G, Di Donato S, Santini D, Falcone A; all the investigators of the Gruppo Oncologico del Nord Ovest.

BMC Cancer. 2017 Jun 9;17(1):408. doi: 10.1186/s12885-017-3360-z.

6.

Dabrafenib plus trametinib in patients with BRAF<sup>V600</sup>-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial.

Davies MA, Saiag P, Robert C, Grob JJ, Flaherty KT, Arance A, Chiarion-Sileni V, Thomas L, Lesimple T, Mortier L, Moschos SJ, Hogg D, Márquez-Rodas I, Del Vecchio M, Lebbé C, Meyer N, Zhang Y, Huang Y, Mookerjee B, Long GV.

Lancet Oncol. 2017 Jun 2. pii: S1470-2045(17)30429-1. doi: 10.1016/S1470-2045(17)30429-1. [Epub ahead of print]

PMID:
28592387
7.

Evaluation of a novel line probe assay to detect resistance to pyrazinamide, a key drug used for tuberculosis treatment.

Driesen M, Kondo Y, de Jong BC, Torrea G, Asnong S, Desmaretz C, Mostofa KSM, Tahseen S, Whitfield MG, Cirillo DM, Miotto P, Cabibbe AM, Rigouts L.

Clin Microbiol Infect. 2017 Jun 3. pii: S1198-743X(17)30287-2. doi: 10.1016/j.cmi.2017.05.026. [Epub ahead of print]

8.

Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer.

von Minckwitz G, Procter M, de Azambuja E, Zardavas D, Benyunes M, Viale G, Suter T, Arahmani A, Rouchet N, Clark E, Knott A, Lang I, Levy C, Yardley DA, Bines J, Gelber RD, Piccart M, Baselga J; APHINITY Steering Committee and Investigators.

N Engl J Med. 2017 Jun 5. doi: 10.1056/NEJMoa1703643. [Epub ahead of print]

9.

Rationale and protocol of MetNET-2 trial: Lanreotide Autogel plus metformin in advanced gastrointestinal or lung neuroendocrine tumors.

Pusceddu S, Prinzi N, Lo Russo G, Femia D, Milione M, Perrone F, Tamborini E, Concas L, Pulice I, Vernieri C, Corti F, Buzzoni R, de Braud F.

Future Oncol. 2017 Jun 5. doi: 10.2217/fon-2017-0132. [Epub ahead of print]

PMID:
28580793
10.

Effect of a food supplement containing berberine, monacolin K, hydroxytyrosol and coenzyme Q10 on lipid levels: a randomized, double-blind, placebo controlled study.

D'Addato S, Scandiani L, Mombelli G, Focanti F, Pelacchi F, Salvatori E, Di Loreto G, Comandini A, Maffioli P, Derosa G.

Drug Des Devel Ther. 2017 May 23;11:1585-1592. doi: 10.2147/DDDT.S128623. eCollection 2017.

11.

Outcome evaluation of patients with limited brain metastasis from malignant melanoma, treated with surgery, radiation therapy and targeted therapy.

Pessina F, Navarria P, Tomatis S, Cozzi L, Franzese C, Di Guardo L, Ascolese AM, Reggiori G, Franceschini D, Del Vecchio M, Bello L, Marta Scorsetti.

World Neurosurg. 2017 May 31. pii: S1878-8750(17)30833-1. doi: 10.1016/j.wneu.2017.05.131. [Epub ahead of print]

PMID:
28578123
12.

Identification of the resection severity index as a significant independent prognostic factor for early mortality and observed survival >5 and >10 years after liver resection for hepatocellular carcinoma.

Gwiasda J, Schulte A, Kaltenborn A, Ramackers W, Kleine M, Beetz O, Klempnauer J, Emmanouilidis N, Schrem H.

Surg Oncol. 2017 Jun;26(2):178-187. doi: 10.1016/j.suronc.2017.03.004. Epub 2017 Mar 14.

PMID:
28577724
13.

Unmanipulated haploidentical stem cell transplantation in adults with acute lymphoblastic leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT.

Santoro N, Ruggeri A, Labopin M, Bacigalupo A, Ciceri F, Gülbaş Z, Huang H, Afanasyev B, Arcese W, Wu D, Koc Y, Tischer J, Santarone S, Giebel S, Mohty M, Nagler A.

J Hematol Oncol. 2017 May 30;10(1):113. doi: 10.1186/s13045-017-0480-5.

14.

Simplification to single-tablet regimen of elvitegravir, cobicistat, emtricitabine, tenofovir DF from multi-tablet ritonavir-boosted protease inhibitor plus coformulated emtricitabine and tenofovir DF regimens: week 96 results of STRATEGY-PI.

Arribas JR, DeJesus E, van Lunzen J, Zurawski C, Doroana M, Towner W, Lazzarin A, Nelson M, McColl D, Andreatta K, Swamy R, Szwarcberg J, Nguyen T.

HIV Clin Trials. 2017 May;18(3):118-125. doi: 10.1080/15284336.2017.1330440. Epub 2017 May 30.

PMID:
28555519
15.

Long fusions to S1 with or without pelvic fixation can induce relevant acute variations in pelvic incidence: a retrospective cohort study of adult spine deformity surgery.

Cecchinato R, Redaelli A, Martini C, Morselli C, Villafañe JH, Lamartina C, Berjano P.

Eur Spine J. 2017 May 29. doi: 10.1007/s00586-017-5154-z. [Epub ahead of print]

PMID:
28555312
16.

Effect of Prior Focal Therapy on Perioperative, Oncologic and Functional Outcomes of Salvage Robotic Assisted Radical Prostatectomy.

Nunes-Silva I, Barret E, Srougi V, Baghdadi M, Capogrosso P, Garcia-Barreras S, Kanso S, Tourinho-Barbosa R, Carneiro A, Sanchez-Salas R, Rozet F, Galiano M, Cathelineau X.

J Urol. 2017 May 24. pii: S0022-5347(17)74439-4. doi: 10.1016/j.juro.2017.05.071. [Epub ahead of print]

PMID:
28551444
17.

Integrated cognitive remediation and standard rehabilitation therapy in patients of schizophrenia: persistence after 5years.

Buonocore M, Spangaro M, Bechi M, Baraldi MA, Cocchi F, Guglielmino C, Bianchi L, Mastromatteo A, Bosia M, Cavallaro R.

Schizophr Res. 2017 May 22. pii: S0920-9964(17)30297-9. doi: 10.1016/j.schres.2017.05.022. [Epub ahead of print]

PMID:
28545942
18.

Improvement of ALT decay kinetics by all-oral HCV treatment: Role of NS5A inhibitors and differences with IFN-based regimens.

Cento V, Nguyen THT, Di Carlo D, Biliotti E, Gianserra L, Lenci I, Di Paolo D, Calvaruso V, Teti E, Cerrone M, Romagnoli D, Melis M, Danieli E, Menzaghi B, Polilli E, Siciliano M, Nicolini LA, Di Biagio A, Magni CF, Bolis M, Antonucci FP, Di Maio VC, Alfieri R, Sarmati L, Casalino P, Bernardini S, Micheli V, Rizzardini G, Parruti G, Quirino T, Puoti M, Babudieri S, D'Arminio Monforte A, Andreoni M, Craxì A, Angelico M, Pasquazzi C, Taliani G, Guedj J, Perno CF, Ceccherini-Silberstein F.

PLoS One. 2017 May 18;12(5):e0177352. doi: 10.1371/journal.pone.0177352. eCollection 2017.

19.

Concerning CT features used to select patients for treatment of peritoneal metastases, a pictoral essay.

Sugarbaker PH, Sardi A, Brown G, Dromain C, Rousset P, Jelinek JS.

Int J Hyperthermia. 2017 Apr 9:1-35. doi: 10.1080/02656736.2017.1317368. [Epub ahead of print]

PMID:
28540832
20.

Evidence-Based Treatment Options in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck.

Argiris A, Harrington KJ, Tahara M, Schulten J, Chomette P, Ferreira Castro A, Licitra L.

Front Oncol. 2017 May 9;7:72. doi: 10.3389/fonc.2017.00072. eCollection 2017. Review.

Supplemental Content

Loading ...
Support Center